Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

RTTNews | vor 954 Tagen
Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

(RTTNews) - Incyte Corp. (INCY) announced Friday that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD) use in the treatment of certain types of myelofibrosis (MF), polycythemia vera (PV) and graft-versus-host disease (GVHD).

The complete response letter states that the FDA cannot approve the application in its present form. The FDA acknowledged that the study submitted in the New Drug Application (NDA) met its objective of bioequivalence based on area under the curve (AUC) parameters but identified additional requirements for approval.

Incyte intends to meet with the FDA to determine appropriate next steps.

The NDA was based on two studies designed to show that ruxolitinib XR tablets are dosage strength proportional and bioequivalent to Jakafi (ruxolitinib) tablets.

read more
Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Corp. (INCY) on Tuesday reported net income of $201.10 million or $0.89 per share for the fourth quarter, sharply higher than $28.46 million or $0.13 per share in the prior-year quarter.
RTTNews | vor 628 Tagen
Incyte Q1 Results Top Estimates

Incyte Q1 Results Top Estimates

Incyte Corp. (INCY) on Tuesday reported net income of $161.43 million or $0.72 per share for the first quarter, up from $149.46 million or $0.67 per share in the prior-year quarter.
RTTNews | vor 1188 Tagen
Sensex, Nifty Struggle For Direction In Early Trade

Sensex, Nifty Struggle For Direction In Early Trade

Indian shares struggled for direction on Monday ahead of a big week for earnings, with around 200 prominent companies scheduled to report their quarterly earnings results.
RTTNews | vor 1Std 25 Minuten
Australian Market Slashes Early Losses In Mid-market

Australian Market Slashes Early Losses In Mid-market

The Australian stock market is slashing its early losses in mid-market trading on Monday, but extending the losses in the previous four sessions, despite the broadly positive cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is staying below the 8,850 level, with weakness in materials stocks partially offset by gains in energy, financial and technology stocks.
RTTNews | vor 2Std 36 Minuten
Asian Markets Track Wall Street Higher

Asian Markets Track Wall Street Higher

Asian stock markets are trading mostly higher on Monday, following the broadly positive cues from Wall Street on Friday, as a temporary tariff truce materialized between the U.S. and China wherein China agreed to buy more U.S. energy. This gave fresh optimism about smooth trade relations between the two major oil consumers of the world. Asian markets closed mixed on Friday.
RTTNews | vor 2Std 42 Minuten
Sensex, Nifty Likely To Open On Cautious Note

Sensex, Nifty Likely To Open On Cautious Note

Indian shares look set to open on a subdued note Monday after having snapped their four-week winning streak last week due to profit taking after recent gains to record highs.
RTTNews | vor 3Std 25 Minuten
Thai Shares Tipped To Open To The Upside

Thai Shares Tipped To Open To The Upside

The Thai stock market has moved lower in consecutive trading days, slumping more than 6 points or 0.5 percent along the way. The Stock Exchange of Thailand now sits just shy of the 1,310-point plateau although it's expected to open in the green on Monday.
RTTNews | vor 4Std 1 Minuten